Search For "pharmaceutical"
Delhi govt launches one-year diploma course in Meditation, Yoga Sciences
Updated : 4 years, 9 months ago IST
New Delhi [India], June 20 (ANI): Delhi Chief Minister Arvind Kejriwal on Sunday launched a one-year diploma course in 'Meditation and Yoga Sciences', in which around 450 candidates have enrolled themselves.
Read More
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D COVID-19 v
Updated : 4 years, 9 months ago IST
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Read More
Indian pharma companies' sales to rise after resilience in FY21: Fitch
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 15 (ANI): Indian pharmaceutical companies' sales will grow robustly in the financial year ending March 2022 (FY22) as sales normalise in categories affected by the pandemic in previous year, Fitch Ratings has said.
Read More
Trade Margin for Oxygen Concentrators capped at 70 per cent
Updated : 4 years, 9 months ago IST
New Delhi [India], June 11 (ANI): The Trade Margin for Oxygen Concentrators has been capped at 70 per cent on the Price to Distributer (PTC) level by the National Pharmaceutical Pricing Authority (NPPA).
Read More
DRDO invites Expression of Interest for bulk production of COVID drug 2-DG
Updated : 4 years, 9 months ago IST
New Delhi [India], June 9 (ANI): The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industr
Read More
Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 9 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India.
Read More
Centre caps prices of oxygen concentrators
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has capped the trade margin for oxygen concentrators at 70 per cent, the Ministry of Chemicals and Fertilizers said on Friday.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent
Read More
Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 4 years, 10 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 m
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More
Glenmark's consolidated revenues grow 2.8% to Rs. 1,09,439 Mn in FY21
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 31 (ANI/PRNewswire): EBITDA growth of 22.7 per cent to Rs 20,844 Mn with margins of 19 per cent. Consolidated Net Profit of Rs 9,701 Mn with growth of 25 per cent in FY21.
Read More